Cargando…

Circulating tumor DNA use in a community oncology practice

BACKGROUND: This retrospective single center study aimed to describe circulating tumor DNA (ctDNA) comprehensive genomic profiling (CGP) utilization in a community practice for patients with advanced solid tumors. METHODS: All patients were included who were seen at the Scripps Hillcrest Oncology Cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chamberlain, Erin D., Costantini, Carrie L., Xavier, Marin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798503/ https://www.ncbi.nlm.nih.gov/pubmed/35116787 http://dx.doi.org/10.21037/tcr.2019.03.15

Ejemplares similares

Circulating tumor DNA analysis in the era of precision oncology
por: Said, Rabih, et al.
Publicado: (2020)

Clinical Circulating Tumor DNA Testing for Precision Oncology
por: Kim, Hyunji, et al.
Publicado: (2023)

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
por: Addanki, Sridevi, et al.
Publicado: (2022)

Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
por: Arisi, Maria F., et al.
Publicado: (2022)

Designing circulating tumor DNA-based interventional clinical trials in oncology
por: Araujo, Daniel V., et al.
Publicado: (2019)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
por: Deveson, Ira W., et al.
Publicado: (2021)

Application of circulating tumor DNA in prospective clinical oncology trials – standardization of preanalytical conditions
por: van Dessel, Lisanne F., et al.
Publicado: (2017)

Origins, structures, and functions of circulating DNA in oncology
por: Thierry, A. R., et al.
Publicado: (2016)

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
por: Malla, Midhun, et al.
Publicado: (2022)

Circulating tumor cell profiling for precision oncology
por: Labib, Mahmoud, et al.
Publicado: (2021)

Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer
por: Hayashi, Takaomi, et al.
Publicado: (2022)

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
por: Reece, Mifanwy, et al.
Publicado: (2019)

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018)

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533
por: Madanat-Harjuoja, Laura M., et al.
Publicado: (2022)

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma
por: Affolter, Kajsa E., et al.
Publicado: (2021)

Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges
por: Chan, Hiu Ting, et al.
Publicado: (2022)

Assessing tumor heterogeneity: integrating tissue and circulating tumor DNA (ctDNA) analysis in the era of immuno-oncology - blood TMB is not the same as tissue TMB
por: Fridland, Stanislav, et al.
Publicado: (2021)

Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Wang, Ruoxiang, et al.
Publicado: (2016)

Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
por: Tuaeva, Natalia O., et al.
Publicado: (2019)

Characterization of DNA Methylation in Circulating Tumor Cells
por: Pixberg, Constantin F., et al.
Publicado: (2015)

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
por: van Velzen, Merel J. M., et al.
Publicado: (2022)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Circulating tumor cells: quintessential precision oncology presenting challenges for biology
por: Morris, Rebecca J.
Publicado: (2017)

Tumor and host characteristics of small cell lung cancer (SCLC) in U.S. community oncology practice
por: Richards, Donald, et al.
Publicado: (2015)

Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
por: Lu, Jun-Liang, et al.
Publicado: (2016)

Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas
por: Przybyl, Joanna, et al.
Publicado: (2019)

Practical guidance for telemedicine use in neuro-oncology
por: Strowd, Roy E, et al.
Publicado: (2022)

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
por: Cho, Byoung Chul, et al.
Publicado: (2022)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice
por: Kim, Kyung-Hee, et al.
Publicado: (2023)

Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
por: Heitzer, E., et al.
Publicado: (2022)

Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma
por: Gouda, M.A., et al.
Publicado: (2021)

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer
por: Hennigan, S. Thomas, et al.
Publicado: (2019)

Fragment Length of Circulating Tumor DNA
por: Underhill, Hunter R., et al.
Publicado: (2016)

Circulating Tumor DNA in Pediatric Cancer
por: Doculara, Louise, et al.
Publicado: (2022)

Circulating tumor DNA in Hodgkin lymphoma
por: Maco, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1rkbgc59gkoim3ecc1u564of6k